UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Fungal genetics and biology, ISSN 1087-1845, 10/2019, Volume 131, pp. 103243 - 103243
Fluconazole - pharmacology | Tetrazoles - pharmacology | Humans | Azoles - therapeutic use | Drug Resistance, Multiple, Fungal - physiology | Candidiasis - microbiology | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Aminopyridines - therapeutic use | Candidiasis - drug therapy | 14-alpha Demethylase Inhibitors - therapeutic use | Echinocandins - pharmacology | Pyridines - therapeutic use | Antifungal Agents - pharmacology | Amphotericin B - pharmacology | Azoles - pharmacology | Isoxazoles - pharmacology | 14-alpha Demethylase Inhibitors - pharmacology | Aminopyridines - pharmacology | Echinocandins - therapeutic use | Tetrazoles - therapeutic use | Pyridines - pharmacology | Candida - drug effects | Isoxazoles - therapeutic use | Amphotericin B - therapeutic use | Index Medicus
Journal Article
Expert opinion on drug metabolism & toxicology, ISSN 1742-5255, 04/2014, Volume 10, Issue 4, pp. 561 - 580
opportunistic infections | antiretrovirals | human immunodeficiency virus infection | pharmacodynamic | pharmacokinetic | azole antifungals | therapeutic drug monitoring | clinical recommendations | Therapeutic drug monitoring | Antiretrovirals | Opportunistic infections | Human immunodeficiency virus infection | Pharmacodynamic | Azole antifungals | Clinical recommendations | Pharmacokinetic | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Toxicology | Life Sciences & Biomedicine | Science & Technology | Anti-Retroviral Agents - therapeutic use | Humans | AIDS-Related Opportunistic Infections - drug therapy | Organophosphates - therapeutic use | HIV Protease Inhibitors - therapeutic use | Antifungal Agents - therapeutic use | Benzoxazines - therapeutic use | Itraconazole - therapeutic use | Drug Interactions | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | HIV Infections - complications | Mycoses - drug therapy | Voriconazole | Echinocandins - therapeutic use | Ritonavir - therapeutic use | HIV Infections - drug therapy | Mycoses - complications | Carbamates - therapeutic use | Drug Monitoring | Triazoles - therapeutic use | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2007, Volume 51, Issue 7, pp. 2587 - 2590
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Itraconazole - therapeutic use | Microbial Sensitivity Tests | Ketoconazole - therapeutic use | Pyrimidines - therapeutic use | Flucytosine - therapeutic use | Caspofungin | Voriconazole | Echinocandins | Peptides, Cyclic - therapeutic use | Amphotericin B - therapeutic use | In Vitro Techniques | Mucormycosis - drug therapy | Lipopeptides | Triazoles - therapeutic use | Index Medicus | Susceptibility
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 09/2017, Volume 77, Issue 14, pp. 1505 - 1518
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Polyenes - chemistry | Humans | Acetamides - pharmacology | Antibodies, Monoclonal - therapeutic use | Antifungal Agents - chemistry | Azoles - therapeutic use | Antifungal Agents - therapeutic use | Acetamides - therapeutic use | Polyenes - therapeutic use | Pyrroles - therapeutic use | Echinocandins - pharmacology | Antifungal Agents - pharmacology | Antibodies, Monoclonal - pharmacology | Polyenes - pharmacology | Piperazines - therapeutic use | Pyrimidines - pharmacology | Azoles - pharmacology | Piperazines - pharmacology | Chemistry, Pharmaceutical | Azoles - chemistry | Pyrroles - pharmacology | Pyrimidines - therapeutic use | Mycoses - drug therapy | Echinocandins - therapeutic use | Drug Development | Drugs | Fungicides | Toxicity | Antibodies | Tetrazoles | Infections | Fungal infections | Drug development | Tropical diseases | Fungi | Glucan | Synthesis | Heterocyclic compounds | Polyenes | Meningitis | Immunoglobulins | Mortality | Oral administration | Chitin | Bioavailability | FDA approval | Meningoencephalitis | Azoles | Inhibitors | Amphotericin B | Monoclonal antibodies | Glycosylphosphatidylinositol | Mutation
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 6/2009, Volume 48, Issue 12, pp. 1743 - 1751
Antifungals | Mucormycosis | Granulocytes | Clinical Practice | Lipids | Infections | Mice | Fungal infections | Diabetes | Dosage | Zygomycosis | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Tropical mycoses | Mycoses | Biological and medical sciences | Phycomycoses | Medical sciences | Benzoates - therapeutic use | Mucormycosis - diagnosis | Humans | Clinical Trials as Topic | Antifungal Agents - therapeutic use | Case Management | Polyenes - therapeutic use | Echinocandins - therapeutic use | Amphotericin B - therapeutic use | Drug Therapy, Combination | Mucormycosis - drug therapy | Immunologic Factors - therapeutic use | Triazoles - therapeutic use | Clinical trials | Therapy | Index Medicus
Journal Article
6.
Full Text
Breaking the Mold
: A Review of Mucormycosis and Current Pharmacological Treatment Options
9/2016, Volume 50, Issue 9, 11
posaconazole | Mucorales | isavuconazole | amphotericin B | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Mucorales - isolation & purification | Lipopeptides - therapeutic use | Humans | Middle Aged | Virulence | Male | Mucorales - pathogenicity | Antifungal Agents - therapeutic use | Mucorales - classification | Echinocandins - administration & dosage | Nitriles - administration & dosage | Pyridines - adverse effects | Amphotericin B - administration & dosage | Mucormycosis - drug therapy | Drug Resistance, Fungal | Pyridines - therapeutic use | Triazoles - therapeutic use | Pyridines - administration & dosage | Mucorales - drug effects | Amphotericin B - adverse effects | Debridement | Echinocandins - adverse effects | Mucormycosis - microbiology | Lipopeptides - adverse effects | Echinocandins - therapeutic use | Lipopeptides - administration & dosage | Amphotericin B - therapeutic use | Nitriles - adverse effects | Antifungal Agents - administration & dosage | Nitriles - therapeutic use | Index Medicus
Book Review
Current medicinal chemistry, ISSN 0929-8673, 02/2011, Volume 18, Issue 5, pp. 733 - 766
Antifungal | Lead compounds | Structure-activity relationship | Rational drug design | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Glucosyltransferases - antagonists & inhibitors | Humans | Sterol 14-Demethylase - therapeutic use | Naphthoquinones - therapeutic use | Structure-Activity Relationship | Drug Discovery | Enzyme Inhibitors - therapeutic use | Antifungal Agents - therapeutic use | Mycoses - drug therapy | Echinocandins - therapeutic use | Carbazoles - therapeutic use | 14-alpha Demethylase Inhibitors - therapeutic use | Triazoles - therapeutic use | Infection | Drug discovery | Pharmacokinetics | Toxicity | Antifungal agents | Index Medicus
Journal Article
Mycopathologia (1975), ISSN 0301-486X, 8/2016, Volume 181, Issue 7, pp. 575 - 581
Life Sciences | Antifungals | Medical Microbiology | Microbial Ecology | Microbiology | Spondylodiscitis | Aspergillosis | Vertebral osteomyelitis | Aspergillus terreus | Immunocompetent | Plant Sciences | Eukaryotic Microbiology | Life Sciences & Biomedicine | Mycology | Science & Technology | Aspergillus - classification | Discitis - drug therapy | Lipopeptides - therapeutic use | Humans | Discitis - pathology | Aspergillosis - diagnosis | Male | Antifungal Agents - therapeutic use | Tuberculosis, Pulmonary - complications | Young Adult | Aspergillosis - pathology | Aspergillus - isolation & purification | Spine - pathology | Aspergillosis - drug therapy | Voriconazole - therapeutic use | Magnetic Resonance Imaging | Spine - diagnostic imaging | Microscopy | Biopsy | Spine - microbiology | Aspergillosis - microbiology | Histocytochemistry | Echinocandins - therapeutic use | Discitis - etiology | Microbiological Techniques | Discitis - microbiology | Infection | Care and treatment | Immunotherapy | HIV testing | Mycoses | Backache | Health aspects | Index Medicus | Spine/pathology | Lipopeptides/therapeutic use | Discitis/pathology | Aspergillosis/drug therapy | Aspergillus/isolation & purification | Caspofungin | Echinocandins/therapeutic use | Spine/microbiology | Voriconazole/therapeutic use | Discitis/microbiology | Aspergillosis/diagnosis | Discitis/etiology | Aspergillus/classification | Spine/diagnostic imaging | Microbiology and Parasitology | Aspergillosis/pathology | Aspergillosis/microbiology | Discitis/drug therapy | Antifungal Agents/therapeutic use | Tuberculosis, Pulmonary/complications
Journal Article